![](/img/cover-not-exists.png)
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximabâresistant head and neck cancer: The MAESTRO study
Seiwert, Tanguy Y., Kochanny, Sara, Wood, Kevin, Worden, Francis P., Adkins, Douglas, Wade, James L., Sleckman, Bethany G., Anderson, Daniel, Brisson, Ryan J., Karrison, Theodore, Stadler, Walter M.,Journal:
Cancer
DOI:
10.1002/cncr.32929
Date:
May, 2020
File:
PDF, 272 KB
2020